NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)

Notice Title

NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)

Notice Description

Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders. The Condition can be difficult to diagnose because initial presentation can be non-specific and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects Adults. Children are treated in paediatric haematology centres and are outside the scope of this process.

Lot Information

Thrombotic Thrombocytopenic Purpura (TTP) - London and the South East (Kent, Surrey, East & West Sussex)

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting interested Providers to bid for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. There are patient flows to London from all over the South East. Commissioners have considered establishing one specialist provider for all of London and the South East and this is the default commissioner position. Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas - (Lot 2)), to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1). The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres centre in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.

Publication & Lifecycle

Open Contracting ID

ocds-h6vhtk-02a260

Publication Source

Find A Tender Service

Latest Notice

https://www.find-tender.service.gov.uk/Notice/012086-2021

Current Stage

Tender

All Stages

Planning, Tender

Procurement Classification

Notice Type

Planning Notice

Procurement Type

Standard

Procurement Category

Services

Procurement Method

Open

Procurement Method Details

Open procedure

Tender Suitability

Not specified

Awardee Scale

Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

---

CPV Codes

85000000 - Health and social work services

85100000 - Health services

Notice Value(s)

Tender Value

£54,943,200 £10M-£100M

Lots Value

£90,943,200 £10M-£100M

Awards Value

Not specified

Contracts Value

Not specified

Notice Dates

Publication Date

28 May 20215 years ago

Submission Deadline

25 Jun 2021Expired

Future Notice Date

4 May 2021Expired

Award Date

Not specified

Contract Period

Not specified - Not specified

Recurrence

Not specified

Notice Status

Tender Status

Active

Lots Status

Active

Awards Status

Not Specified

Contracts Status

Not Specified

Contracting Authority (Buyer)

Main Buyer

NHS England - Specialised Commissioning)

Additional Buyers

NHS England - Specialised Commissioning

Contact Name

Available with D3 Tenders Premium →

Contact Email

Available with D3 Tenders Premium →

Contact Phone

Available with D3 Tenders Premium →

Buyer Location

Locality

LONDON

Postcode

SE1 6LH

Postcode Area

South East London

Country

England

---

Major Region (ITL 1)

TLI London

Basic Region (ITL 2)

TLI4 Inner London - East

Small Region (ITL 3)

TLI44 Lewisham and Southwark

Delivery Location

TLC North East (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLJ2 Surrey, East and West Sussex, TLJ4 Kent, TLK South West (England)

---

Local Authority

Southwark

Electoral Ward

St George's

Westminster Constituency

Bermondsey and Old Southwark

Notice URLs

• https://uk.eu-supply.com/ctm/supplier/publictenders?B=UK
• https://uk.eu-supply.com/login.asp?B=AGCSU&target=
• https://www.ardengemcsu.nhs.uk/
• https://www.england.nhs.uk/commissioning/spec-services/